NONOF News and Press, Novo Nordisk - Class B From 03/07/26

2026-03-07 08:19:03 ET More on Hims & Hers Health, Novo Nordisk CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry Hims & Hers Health: Leaving GLP-1s Behind Pricing Pressure And Panic: What The Market May Be Missing In Novo N...

2026-03-06 18:13:23 ET Intro When Novo Nordisk A/S ( NVO ) CEO Maziar "Mike" Doustdar and Eli Lilly and Company ( LLY ) CEO David Ricks stood shoulder to shoulder in the White House Oval Office during their drug pricing deal ‑announcement ceremony with the...

2026-03-06 09:30:00 ET Eli Lilly: Are The Best Days Over? It seems like the market is ready to look past the previous winners in the healthcare sector, and that includes Eli Lilly ( LLY ), unfortunately. It shouldn't have escaped the lens of investors that LLY gained just under ...

2026-03-06 08:17:19 ET More on Novo Nordisk A/S Pricing Pressure And Panic: What The Market May Be Missing In Novo Nordisk Eli Lilly Vs. Novo Nordisk: The Valuation Gap Is Unreasonable Why I'm Still Bullish On Novo Nordisk Despite Recent Setbacks Novo’...

2026-03-06 06:05:00 ET Listen below or on the go via Apple Podcasts and Spotify U.S. issues 30 day waiver (1:00) and considers requiring permits for global AI chip sales (2:45) China approves Pfizer’s GLP-1 (4:00)... Read the full article on Seeking Alph...

2026-03-05 06:00:58 ET Performance assessment Pfizer ( PFE ) has outperformed the S&P500 broader market index since my last update on the stock: Performance since Author's Last Article on PFE (Seeking Alpha, Author's Last Article on PFE) Read the fu...

2026-03-04 08:23:24 ET More on Novo Nordisk A/S Pricing Pressure And Panic: What The Market May Be Missing In Novo Nordisk Eli Lilly Vs. Novo Nordisk: The Valuation Gap Is Unreasonable Why I'm Still Bullish On Novo Nordisk Despite Recent Setbacks Novo’...

2026-03-04 05:33:01 ET Alzheimer’s drug development remains fraught with failure, but antioxidant-focused strategies show the most promise compared to anti-amyloid, anti-tau, or anti-inflammatory approaches. Novo Nordisk ( NVO ) may benefit if its GLP-1 receptor a...

2026-03-03 13:50:10 ET The last time I spoke about Prothena Corporation plc ( PRTA ), it was in a Seeking Alpha article entitled " Prothena: Despite Phase 3 Trial Failure, Other Neurodegenerative Programs In Place ." I went over two of its main clinical programs, which were ...

2026-03-03 12:09:49 ET More on Novo Nordisk, Aspen Pharmacare Pricing Pressure And Panic: What The Market May Be Missing In Novo Nordisk Eli Lilly Vs. Novo Nordisk: The Valuation Gap Is Unreasonable Why I'm Still Bullish On Novo Nordisk Despite Recent Setbacks ...